Medicare restrictions hinder access to newly FDA-approved Alzheimer's treatment, says health policy expert

According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s. This number is estimated to increase to 13 million by 20-50

Related Keywords

United States ,Americans ,Kenneth Thorpe ,Alzheimer Association ,Partnership To Fight Chronic Disease ,Department Of Health Policy Management ,Health Policy ,Fight Chronic ,Health Medical Pharma ,Alzheimer X27s Disease In African Americans ,Pharmaceutical Industry ,Medicare ,Alzheimer X27s Disease ,Clinical Trial ,Healthcare Reform In The United States ,Food And Drug Administration ,Federal Assistance In The United States ,Aducanumab ,